Déjà vu all over again: skin cap still contains a high-potency glucocorticosteroid.
Swanson
David L
DL
Pittelkow
Mark R
MR
Benson
Linda M
LM
Hawkridge
Adam M
AM
Muddiman
David C
DC
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000737:chemistry* / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008422:Materials Testing; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012680:Sensitivity and Specificity
D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents